Previous Close | 0.0600 |
Open | 0.0600 |
Bid | 0.0600 x 0 |
Ask | 0.0650 x 0 |
Day's Range | 0.0600 - 0.0650 |
52 Week Range | 0.0600 - 0.3000 |
Volume | |
Avg. Volume | 136,793 |
Market Cap | 11.623M |
Beta (5Y Monthly) | 1.34 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) and ("IntroMedic") jointly announce that they have entered a non-binding memorandum of understanding ("MOU"). IntroMedic is a leading innovator in global capsule endoscopy technology and medical imaging analysis whose objective is to always improve the quality of its patented imaging and analysis medical offerings. Further detail can be found on IntroMedic's website: IntroMedic
("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) announces a dual rollout strategy on the commercialization of Nexcompress.™ NexCompress is part of NexOptic's ALIIS™ suite of artificial intelligence imaging solutions and enables significant bandwidth reduction when coupled with existing video compression technologies.